Indian Patent Office rejects BPaL patent, doctors urge caution
The story in brief
The Indian Patent Office rejected the patent application for BPaL, a TB treatment, sparking concerns among doctors about access. In Mumbai, 60% of drug-resistant TB cases are ineligible for BPaL-M due to age and comorbidities. Health activists warn of potential bias in healthcare access.